![Alliance News](https://static.lse.co.uk/images/news-logos/alliance-news-logo.png)
Thu, 12th Jan 2017 08:05
(ShareCast News) - Royal Dutch Shell shares are worth buying for the dividend, according to the Sunday Times's Inside The City column. Acquiring BG Group in 2015 after oil prices had already collapsed, stretched Shell's balance sheet close to its limit, but it still pays out a hefty amount. Incoming
Read more(ShareCast News) - Private healthcare provider Spire Healthcare surged on Friday following a report that peer Mediclinic was preparing a bid for the remainder of the company. Betaville cited people familiar with the matter as saying that Mediclinic was working with Morgan Stanley and could be weeks
Read more(ShareCast News) - Merlin Entertainments: UBS reiterates buy with a target price of 540p. Fenner: Jefferies maintains buy with a 205p target. Randgold Resources: UBS upgrades to buy with a 9750p target. Lloyds: Berenberg reiterates hold with a 55p target. BAE Systems: Goldman Sachs keeps at buy w
Read more(ShareCast News) - Spire Healthcare reported a jump in pre-tax profit for the six months to the end of June as revenues grew and the company reiterated its guidance for the year. Pre-tax profit rose 16.8% to £46m on revenue of £469.5m, up from £449.8m in the same period a year ago. Analysts had been
Read more(ShareCast News) - Ibstock: Jefferies reiterates buy with a target price of 190p. Legal & General: Barclays maintains equal-weight with a 194p target. Glencore: UBS reiterates buy with a 220p target. Booker: HSBC stays at neutral with a 200p target. Spire Healthcare: Berenberg reiterates buy with
Read more(ShareCast News) - Hochschild Mining: UBS downgrades to neutral with a target price of 160p. Esure Group: JP Morgan keeps at overweight with a 330p target. Royal Dutch Shell: RBC reiterates outperform with a target price of 2000p and JP Morgan stays atneutral with a target price of 1630p. National
Read more(ShareCast News) - Spire Healthcare's deputy chairman and senior independent director John Gildersleeve will stand down from the board for personal reasons. The FTSE 250 private hospitals operator said Gildersleeve will stay on as a director until a new independent non-executive director has been ap
Read more